Overexpression of miR-100 in stem cells derived from basal-like breast cancers causes loss of stemness, induction of luminal breast cancer markers and response to endocrine therapy. We, therefore, explored miR-100 as a novel biomarker in patients with luminal breast cancer.

MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer

Petrelli, Annalisa;Bellomo, Sara Erika;Medico, Enzo;Berrino, Enrico;Provero, Paolo;Sapino, Anna;Giordano, Silvia;
2020-01-01

Abstract

Overexpression of miR-100 in stem cells derived from basal-like breast cancers causes loss of stemness, induction of luminal breast cancer markers and response to endocrine therapy. We, therefore, explored miR-100 as a novel biomarker in patients with luminal breast cancer.
2020
5
5
e000937
e000937
endocrine therapy; luminal breast cancer; miR-100; prognosis; response prediction
Petrelli, Annalisa; Bellomo, Sara Erika; Sarotto, Ivana; Kubatzki, Franziska; Sgandurra, Paola; Maggiorotto, Furio; Di Virgilio, Maria Rosaria; Ponzon...espandi
File in questo prodotto:
File Dimensione Formato  
2020-MiR.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 1.69 MB
Formato Adobe PDF
1.69 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1766966
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 10
social impact